Advertisement
Skip to Content

Mesa Laboratories Inc MLAB Stock Quote

| Rating as of

NASDAQ: MLAB

Last close prices updated as of Feb 07, 2023, 4:00 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 183.25
  • Sector Technology
  • Industry Scientific & Technical Instruments
  • Investment Style Small Growth
  • Day Range 176.00  –  185.42
  • Year Range 114.21  –  279.60
  • Market Cap 979.6864 Mil
  • Volume / Avg 61,797.0 /  81,895.5
  • Price / Sales 4.41
  • Price / Book 2.53
  • Forward Div Yield 0.35%
  • Trailing Div Yield 0.44%

Morningstar‘s Stock Analysis MLAB

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics MLAB

Company Profile MLAB

Business Description

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization & Disinfection Control, which manufactures and sells biological, cleaning, and chemical indicators. It also provides testing and laboratory services, mainly to the dental industry; Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions; Calibration Solutions division develops, manufactures, and sells quality control and calibration products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters for health and safety purposes; and Clinical Genomics. Its geographical segments include United States and Foreign.

Contact
12100 West Sixth Avenue
Lakewood, CO, 80228
Industry Scientific & Technical Instruments
Employees 681

FAQs for Mesa Laboratories Inc Stock

Yes. MLAB has a forward dividend yield of 0.35%. See MLAB’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

MLAB’s market cap is 979.69 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

MLAB’s stock style is Small Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

MLAB’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare MLAB’s historical performance against its industry peers and the overall market.